Farallon Capital Management’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

Farallon Capital Management’s Portfolio RVMDW Stock Details RVMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$209K	Hold	120,085	–	–	﹤0.01%	140
2025 Q4	$113K	Hold	120,085	–	–	﹤0.01%	143
2025 Q3	$36K	Hold	120,085	–	–	﹤0.01%	141
2025 Q2	$32.4K	Hold	120,085	–	–	﹤0.01%	143
2025 Q1	$4.56K	Hold	120,085	–	–	﹤0.01%	146
2024 Q4	$19.4K	Hold	120,085	–	–	﹤0.01%	151
2024 Q3	$16.8K	Hold	120,085	–	–	﹤0.01%	159
2024 Q2	$8.56K	Hold	120,085	–	–	﹤0.01%	163
2024 Q1	$19.2K	Hold	120,085	–	–	﹤0.01%	170
2023 Q4	$39.6K	Buy	+120,085	New	+$53.6K	﹤0.01%	143

Other funds holding RVMDW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $196M AUM 84.21% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Farallon Capital Management's RVMDW Position: Q1 2026 in Review

Farallon Capital Management held its Revolution Medicines Inc Warrant (RVMDW) position steady in Q1 2026 at 120,085 shares worth $209K. The position accounts for ﹤0.01% of the portfolio, ranked #140.

Farallon Capital Management first reported a position in RVMDW in Q4 2023 and has held it in 10 quarters since. 23 funds tracked by Wall St. Rank hold RVMDW as of Q1 2026.

Farallon Capital Management held 120,085 shares of Revolution Medicines Inc Warrant worth $209K as of Q1 2026.
Farallon Capital Management left its Revolution Medicines Inc Warrant share count unchanged in Q1 2026.
Revolution Medicines Inc Warrant made up ﹤0.01% of Farallon Capital Management's portfolio in Q1 2026, its #140 holding.
Farallon Capital Management first reported a position in Revolution Medicines Inc Warrant in Q4 2023 and has held it in 10 quarters since.
23 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q1 2026.

Based on Farallon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.